EE03378B1 - Omeprasooli magneesiumisoola sisaldav peroraalne ravimvorm - Google Patents

Omeprasooli magneesiumisoola sisaldav peroraalne ravimvorm

Info

Publication number
EE03378B1
EE03378B1 EE9700014A EE9700014A EE03378B1 EE 03378 B1 EE03378 B1 EE 03378B1 EE 9700014 A EE9700014 A EE 9700014A EE 9700014 A EE9700014 A EE 9700014A EE 03378 B1 EE03378 B1 EE 03378B1
Authority
EE
Estonia
Prior art keywords
omeprazole
dosage form
oral dosage
magnesium salt
form containing
Prior art date
Application number
EE9700014A
Other languages
English (en)
Other versions
EE9700014A (et
Inventor
Inga Bengtsson Siv
Ingmar L�vgren Kurt
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of EE9700014A publication Critical patent/EE9700014A/et
Publication of EE03378B1 publication Critical patent/EE03378B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
EE9700014A 1994-07-08 1995-07-03 Omeprasooli magneesiumisoola sisaldav peroraalne ravimvorm EE03378B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9400679 1994-07-08
PCT/SE1995/000816 WO1996001622A1 (en) 1994-07-08 1995-07-03 New oral pharmaceutical formulation containing magnesium salt of omeprazole

Publications (2)

Publication Number Publication Date
EE9700014A EE9700014A (et) 1997-06-16
EE03378B1 true EE03378B1 (et) 2001-04-16

Family

ID=20393105

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700014A EE03378B1 (et) 1994-07-08 1995-07-03 Omeprasooli magneesiumisoola sisaldav peroraalne ravimvorm

Country Status (15)

Country Link
EP (1) EP0768872A1 (et)
KR (1) KR970704426A (et)
BR (1) BR9508261A (et)
CA (1) CA2193681A1 (et)
CZ (1) CZ379596A3 (et)
EE (1) EE03378B1 (et)
FI (1) FI970058A (et)
HU (1) HUT78132A (et)
IS (1) IS4398A (et)
MX (1) MX9700152A (et)
NO (1) NO970036D0 (et)
NZ (1) NZ289958A (et)
PL (1) PL181265B1 (et)
SK (1) SK166096A3 (et)
WO (1) WO1996001622A1 (et)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9500478D0 (sv) * 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US5900258A (en) * 1996-02-01 1999-05-04 Zeolitics Inc. Anti-bacterial compositions
SI9700186B (sl) 1997-07-14 2006-10-31 Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
SE9704869D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II
SE9704870D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
US6733778B1 (en) 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
SE9802973D0 (sv) 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
US6316020B1 (en) * 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
AU3762801A (en) * 2000-03-09 2001-09-17 Andrew Ilchyshyn Treatment of inflammatory dermatoses comprising erythromycin or clarythromycin metronidazole and a gastrointestinal hydrogen pump inhibitor
EP1133987A1 (en) * 2000-03-09 2001-09-19 Ian Whitcroft Treatment of inflammatory dermatoses with combinations of erythromycin or clarythromycin, metronidazole and a hydrogen pump inhibitor
US8697094B2 (en) * 2002-10-16 2014-04-15 Takeda Pharmaceutical Company Limited Stable solid preparations
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
JP2008502740A (ja) * 2004-06-15 2008-01-31 テバ ファーマシューティカル インダストリーズ リミティド ベンズイミダゾール化合物の安定医薬製剤
CN105106168B (zh) * 2015-08-19 2018-03-06 德州德药制药有限公司 一种埃索美拉唑镁肠胶囊及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
JPH0768125B2 (ja) * 1988-05-18 1995-07-26 エーザイ株式会社 酸不安定化合物の内服用製剤
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
SE9302395D0 (sv) * 1993-07-09 1993-07-09 Ab Astra New pharmaceutical formulation

Also Published As

Publication number Publication date
HUT78132A (hu) 2000-06-28
FI970058A0 (fi) 1997-01-07
AU2994795A (en) 1996-02-09
BR9508261A (pt) 1997-12-23
MX9700152A (es) 1997-04-30
CA2193681A1 (en) 1996-01-25
EP0768872A1 (en) 1997-04-23
WO1996001622A1 (en) 1996-01-25
KR970704426A (ko) 1997-09-06
AU695723B2 (en) 1998-08-20
CZ379596A3 (en) 1997-08-13
NO970036L (no) 1997-01-06
NZ289958A (en) 1998-09-24
WO1996001622A8 (en) 1999-12-23
PL318464A1 (en) 1997-06-09
IS4398A (is) 1996-12-17
SK166096A3 (en) 1997-09-10
EE9700014A (et) 1997-06-16
PL181265B1 (pl) 2001-06-29
NO970036D0 (no) 1997-01-06
HU9700039D0 (en) 1997-02-28
FI970058A (fi) 1997-01-07

Similar Documents

Publication Publication Date Title
DE69634053D1 (de) Oral anzuwendende Arzneizusammensetzung enthaltend 2-Methyl-thienobenzodiazepin
EE03378B1 (et) Omeprasooli magneesiumisoola sisaldav peroraalne ravimvorm
PT754061E (pt) Nova forma de dosagem farmaceutica oral
NO934547D0 (no) Oral behandling av Helicobacter-in-feksjon
DK0936913T3 (da) Oralt farmaceutisk præparat indeholdende ibandronat
EE200000395A (et) Peroraalne farmatseutiline pulseeriva vabanemisega annusvorm
DK0577306T3 (da) Præparat til oral hygiejne
DE69327902D1 (de) Zahnseide
ITMI921123A0 (it) Formulazioni farmaceutiche orali contenenti antocianosidi
DE69226936D1 (de) Hydroxamatderivate enthaltende pharmazeutische Zusammensetzungen zur Eisenentfernung
ATA65293A (de) Zahnärztlicher artikulator
ITMI932014A0 (it) Composizioni farmaceutiche orali effervescenti contenenti estrone
DK0831820T3 (da) Oral farmaceutisk sammensætning af piperidinoalkanolforbindelser på opløsningsform
ATA65393A (de) Zahnärztlicher artikulator
IT1272935B (it) Composizione farmaceutica contenente n-acetil-cisteina
SE9402433D0 (sv) New oral pharmaceutical dosage form
DE9210037U1 (de) Dentalartikulator
DE9214267U1 (de) Dentalartikulator
DE9205970U1 (de) Dentalartikulator
DE9207731U1 (de) Dentalartikulator
IL105714A0 (en) Oral dosage forms of risedronate
DK135992D0 (da) Eengangs-mundsproejte
SE9402925D0 (sv) Novel oral pharmaceutical composition
FI965187A (fi) 3-fenyyli-3-hydroksipiperidiinejä sisältäviä terapeuttisia koostumuksia
DK533989D0 (da) Oral doseringsform

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

MM4A Lapsed by not paying the annual fees

Effective date: 20020703